| abstract |
PROBLEM TO BE SOLVED: To provide a new drug for multiple myeloma and a screening method thereof. The antimyeloma agent of the present invention is characterized by containing, as an active ingredient, a substance that suppresses the expression of ARID2, a substance that suppresses the function of ARID2, or a degrading substance that decomposes ARID2. In the screening method for an antimyeloma agent of the present invention, a candidate substance that suppresses the expression of ARID2, suppresses the function of ARID2, or decomposes ARID2 in the coexistence of ARID2 and the candidate substance is selected as the antimyeloma agent. It is a feature. [Selection diagram] Fig. 1 |